Literature DB >> 2969796

Selective insulin action on skin, ovary, and heart in insulin-resistant states.

M E Geffner1, D W Golde.   

Abstract

States of hyperinsulinemia with resistance to insulin action on glucose disposal are frequently associated with proliferative tissue abnormalities of the skin (acanthosis nigricans), ovary, and heart. That insulin may be involved in the pathogenesis of these growth-related abnormalities despite resistance to its metabolic effects mediated through the insulin receptor is suggested by the known ability of high concentrations of insulin to stimulate DNA synthesis and cell proliferation in vitro through the insulin-like growth factor I (IGF-I) receptor. IGF-I receptors are present in skin keratinocytes, some ovarian tissue compartments, and in the heart. Furthermore, ovarian tissue from hyperinsulinemic insulin-resistant women responds to supraphysiologic insulin concentrations in vitro by enhanced steroidogenesis. Cultured, transformed T-lymphocytes from an infant with leprechaunism fail to augment basal-colony formation in response to physiologic insulin concentrations in vitro (compared to a doubling seen in normal subjects), but respond normally to supraphysiologic insulin concentrations, the effect of which is competitively inhibited by a monoclonal antibody to the IGF-I receptor. Thus, insulin action mediated through the IGF-I receptor may initiate growth-promoting tissue effects in the face of limited insulin effect on glucose metabolism. Such spillover actions may add to the morbidity associated with states of clinical insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969796     DOI: 10.2337/diacare.11.6.500

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

1.  Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

Authors:  N Ozbey; A Oncül; Z Buğra; A Vural; F Erzengin; Y Orhan; K Büyüköztürk; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 2.  Lipoatrophic diabetes.

Authors:  H Dörfler; G Rauh; R Bassermann
Journal:  Clin Investig       Date:  1993-04

3.  Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.

Authors:  G S Conway; H S Jacobs
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

4.  Topical insulin accelerates cutaneous wound healing in insulin-resistant diabetic rats.

Authors:  Tianyi Yu; Min Gao; Peilang Yang; Qing Pei; Dan Liu; Di Wang; Xiong Zhang; Yan Liu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

5.  Dilated cardiomyopathy and myocardial infarction secondary to congenital generalized lipodystrophy.

Authors:  Wissam I Khalife; Manal C Mourtada; Jihad Khalil
Journal:  Tex Heart Inst J       Date:  2008

6.  Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach.

Authors:  Sehar Toosy; Ravinder Sodi; Joseph M Pappachan
Journal:  J Diabetes Metab Disord       Date:  2018-11-13

7.  Reversible severe ovarian enlargement in an infant with significant insulin resistance.

Authors:  Lai Lillian; Mikhchi Amir; Ryabets-Lienhard Anna; Geffner Mitchell E; Cheung Clement; Giuffre Danielle
Journal:  Radiol Case Rep       Date:  2021-05-01

8.  Berardinelli-Seip congenital lipodystrophy in two siblings.

Authors:  T S Mohana Rao; Kavya Chennamsetty
Journal:  Indian Dermatol Online J       Date:  2014-11

9.  The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation.

Authors:  Denise S Fernandez-Twinn; Heather L Blackmore; Lee Siggens; Dino A Giussani; Christine M Cross; Roger Foo; Susan E Ozanne
Journal:  Endocrinology       Date:  2012-10-15       Impact factor: 4.736

10.  Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.

Authors:  My-Le Nguyen; Vandana Sachdev; Thomas R Burklow; Wen Li; Megan Startzell; Sungyoung Auh; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.